These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 10731393)

  • 21. Chlamydia pneumoniae antibody levels before coronary events in the Helsinki Heart Study as measured by different methods.
    Paldanius M; Leinonen M; Virkkunen H; Tenkanen L; Sävykoski T; Mänttäri M; Saikku P
    Diagn Microbiol Infect Dis; 2006 Nov; 56(3):233-9. PubMed ID: 16757141
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Epidemiology of Chlamydia pneumoniae in atherosclerosis.
    Saikku P
    Am Heart J; 1999 Nov; 138(5 Pt 2):S500-3. PubMed ID: 10539858
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antibodies against Chlamydia pneumoniae predict the need for elective surgical intervention on small abdominal aortic aneurysms.
    Vammen S; Lindholt JS; Andersen PL; Henneberg EW; Østergaard L
    Eur J Vasc Endovasc Surg; 2001 Aug; 22(2):165-8. PubMed ID: 11472052
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Rupture of the atherosclerotic plaque: is Chlamydia pneumoniae a possible agent?].
    Fazio G; Sutera L; Zito R; Cascio C; Briguglia D; Taormina S; Giammanco A; Assennato P; Novo S
    G Ital Cardiol (Rome); 2006 Dec; 7(12):809-14. PubMed ID: 17294605
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Chlamydia pneumoniae and cytomegalovirus seropositivity, inflammatory markers, and the risk of myocardial infarction at a young age.
    Gattone M; Iacoviello L; Colombo M; Castelnuovo AD; Soffiantino F; Gramoni A; Picco D; Benedetta M; Giannuzzi P
    Am Heart J; 2001 Oct; 142(4):633-40. PubMed ID: 11579353
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Chlamydia pneumonia (and other infective agents) in atherosclerosis and acute coronary syndromes. How good is the evidence?
    Camm AJ; Fox KM
    Eur Heart J; 2000 Jul; 21(13):1046-51. PubMed ID: 10843822
    [No Abstract]   [Full Text] [Related]  

  • 27. Involvement of Chlamydia pneumoniae in atherosclerosis: more evidence for lack of evidence.
    Ieven MM; Hoymans VY
    J Clin Microbiol; 2005 Jan; 43(1):19-24. PubMed ID: 15634945
    [No Abstract]   [Full Text] [Related]  

  • 28. [Infection hypothesis for the pathogenesis of atherosclerosis--caused by Chlamydia pneumoniae?].
    Durkalec J; Hasik J
    Przegl Lek; 1999; 56(4):299-301. PubMed ID: 10494168
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Changes in antibody titers against Chlamydia pneumoniae after coronary angioplasty.
    Yetkin G; Yetkin E; Aksoy Y; Gurbuz OA; Mert A
    Int J Cardiol; 2004 Jun; 95(2-3):293-7. PubMed ID: 15193835
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Chlamydia pneumoniae antibodies associated with altered serum lipid profile.
    Laurila AL; Bloigu A; Näyhä S; Hassi J; Leinonen M; Saikku P
    Int J Circumpolar Health; 1998; 57 Suppl 1():329-32. PubMed ID: 10093301
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Does Chlamydia pneumoniae have a role in atherosclerosis?
    Byers J; Robertson R
    JAAPA; 2002 May; 15(5):50-2, 55-7. PubMed ID: 12063818
    [No Abstract]   [Full Text] [Related]  

  • 32. Design of future intervention studies for Chlamydia pneumoniae in atherosclerosis.
    Grayston JT
    Am Heart J; 1999 Nov; 138(5 Pt 2):S556-7. PubMed ID: 10539875
    [No Abstract]   [Full Text] [Related]  

  • 33. Chlamydia linked to atherosclerosis.
    Mlot C
    Science; 1996 Jun; 272(5267):1422. PubMed ID: 8633229
    [No Abstract]   [Full Text] [Related]  

  • 34. Infectious agents that play a role in atherosclerosis and vasculopathies. What are they? What do we do about them?
    Vercellotti G
    Can J Cardiol; 1999 Apr; 15 Suppl B():13B-15B. PubMed ID: 10350677
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Role of Chlamydia in atherosclerosis].
    Pospísil L
    Vnitr Lek; 2003 Feb; 49(2):91. PubMed ID: 12728571
    [No Abstract]   [Full Text] [Related]  

  • 36. Chlamydia pneumoniae infection and coronary heart disease. Role of C pneumoniae in pathogenesis of atherosclerosis must be determined.
    Numazaki K; Chiba S
    BMJ; 1997 Dec; 315(7121):1538. PubMed ID: 9420502
    [No Abstract]   [Full Text] [Related]  

  • 37. [Chlamydial and human heat shock protein 60 homologues in acute coronary syndromes. (Auto-)immune reactions as a link between infection and atherosclerosis].
    Andrié R; Braun P; Welsch U; Straube E; Höpp HW; Erdmann E; Lüderitz B; Bauriedel G
    Z Kardiol; 2003 Jun; 92(6):455-65. PubMed ID: 12819994
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Chlamydia pneumoniae detection in atherosclerotic plaques in Italy.
    Blasi F; Fagetti L; Allegra L
    J Infect Dis; 2000 Jun; 181 Suppl 3():S444-6. PubMed ID: 10839734
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Chronic Chlamydia pneumonia--complications].
    Tylewska-Wierzbanowska S
    Przegl Epidemiol; 2002; 56 Suppl 4():57-8. PubMed ID: 14750263
    [No Abstract]   [Full Text] [Related]  

  • 40. [Chlamydia pneumoniae and atherosclerosis--the hen, the egg or five feathers?].
    Møller K; Skinhøj P
    Ugeskr Laeger; 1999 Sep; 161(37):5173-4. PubMed ID: 10523951
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.